Biotechnology – Page 2

U.S. Congressional Report Calls for $15 Billion to Bolster Biotech Leadership Amid Rising Chinese Competition

5 months ago talkbio0Tagged Bioeconomy, Biomanufacturing Strategy, Biotech Competition, Biotechnology, Biotechnology Advantage, China, Investments, National Security Commission, Tech Rivalry, U.S.-China, United States

U.S. Biotechnology Advantage, China Biotech Competition, National Security Commission on Emerging Biotechnology, Biotechnology Investment, Biomanufacturing Strategy, U.S.-China Tech Rivalry, Bioeconomy

Rocket Pharmaceuticals Expands Leadership with J&J and AstraZeneca Alumni to Strengthen Gene Therapy Commercialization

5 months ago talkbio0Tagged AstraZeneca, Biotechnology, Chaudhuri, commercial, gene therapy, Kresladi, launch, Market, Mozafancogene Autotemcel, Rocket, Sarbani

Rocket Pharmaceuticals, gene therapy, commercial leadership, Sarbani Chaudhuri, Johnson & Johnson, AstraZeneca, commercial launch, gene therapy market, rare diseases, biotechnology, Kresladi, RP-L102.

Trump Tariffs Could Delay Regulatory Filings for Half of Biotech Companies

5 months ago talkbio0Tagged Biotechnology, Manufacturing costs, regulatory filings, Supply chain disruption, tariffs

Tariffs, Biotechnology, Regulatory filings, Manufacturing costs, Supply chain disruption

MeiraGTx and Hologen AI Form $430M Collaboration to Advance Parkinson’s Gene Therapy

5 months ago talkbio0Tagged Artificial Intelligence, Biotechnology, Clinical Trials, gene therapy, Parkinson 's disease

gene therapy, Parkinson’s disease, artificial intelligence, clinical trials, biotechnology partnership

Nimbus Therapeutics Announces Leadership Transition: Abbas Kazimi Appointed as New CEO

6 months ago talkbio0Tagged Abbas Kazimi, Biotechnology, CEO, computational drug discovery, Nimbus, Transition Mutation

Nimbus Therapeutics, CEO transition, Abbas Kazimi, Jeb Keiper, biotechnology, computational drug discovery

Callio Therapeutics Debuts with $187M to Develop Next-Generation Multi-Payload ADCs for Cancer

6 months ago talkbio0Tagged ADCs, Antibody-Drug, Biotechnology, Cancer Therapeutic Procedure, dual-payload technology, HER2-targeted therapy, Immunostimulating conjugate (antigen), multi-payload, Neoplasms

Multi-payload ADCs, antibody-drug conjugates, oncology, HER2-targeted therapy, dual-payload technology, cancer treatment, biotechnology startup

Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts

7 months ago talkbio0Tagged Biotechnology, cost-cutting measures, Industry, Massachusetts (geographic location), Thermo Fisher Scientific, Viral Vector

Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures

Allakos Discontinues AK006 Development, Cuts 75% of Workforce Amid Strategic Restructuring

7 months ago talkbio0Tagged AK006, Allakos, Biotechnology, Chronic Spontaneous Urticaria, Failure (biologic function), Financial cost, phase 1 trial, restructuring, strategic alternatives

Allakos, AK006, workforce reduction, strategic alternatives, Phase 1 trial failure, chronic spontaneous urticaria (CSU), biotechnology, restructuring costs.